1. 1) Imamura M, Nakura H, Takemoto C. Evaluation of usefulness of pharmaceutical outpatient clinic for cancer patients. Jpn. J. Pharm. Health Care Sci., 36, 85–98 (2010).
2. 2) Imamura M, Matsui Y, Katayama K, Takemoto C, Uehara T. Function and need for a pharmaceutical outpatient clinic run by oncology pharmacy specialists. Jpn. J. Pharm. Health Care Sci., 41, 254–265 (2015).
3. 3) Iwai C, Kobayashi M, Terada T, Yano I, Matumoto S, Yanagihara K, Fukushima M, Inui K. Continuous pharmaceutical consultation regarding chemotherapy combined with TS-1 in outpatients oncology unit: establishment of patient education system and active provision of pharmaceutical care. Jpn. J. Pharm. Health Care Sci., 35, 866–874 (2009).
4. 4) Makihara K, Ohta M, Ueno H, Hama I. Effectiveness of interventions by pharmacists in ensuring safety and efficacy of outpatient chemotherapy prescriptions. Jpn. J. Pharm. Health Care Sci., 36, 880–886 (2010).
5. 5) Mae Y, Yokokawa T, Kawakami K, Yagi N, Suenaga M, Shinozaki E, Matsusaka S, Mizunuma N, Hama T. Usefulness of pharmaceutical outpatient clinic in XELOX therapy. Jpn. J. Pharm. Health Care Sci., 37, 611–615 (2011).